(Total Views: 919)
Posted On: 11/30/2020 8:10:47 AM
Post# of 51

$VSTM News Article - Verastem Oncology Initiates Phase 2 Registration-Directed Trial of VS-6766 and Defactinib in Recurrent Low-Grade Serous Ovarian Cancer https://marketwirenews.com/news-releases/vera...85465.html


My Twitter: WhyteStocks